Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

Moderna is under fire for not doing enough to vaccinate the world, particularly low-income countries — and the Biden administration is being criticized for not doing enough to force Moderna's hand.

Why it matters: Low-income countries are desperate for more vaccine, and experts warn that higher levels of global spread will increase the likelihood of a vaccine-resistant variant emerging.

Driving the news: A top Biden official publicly threatened Moderna with more aggressive government action if it doesn't voluntarily provide enough vaccines to the global initiative COVAX at not-for-profit prices, which the administration has asked it to do.

  • "Do not underestimate the resolve of the United States government in addressing these issues," David Kessler, the Biden administration's chief science officer of the COVID-19 response, said at a panel event yesterday.
  • "I think these companies understand our authorities and understand we would not be afraid to use them," Kessler added. He said Moderna has the capacity to make at least 1 billion extra doses in the short term.

State of play: Moderna has been supplying its vaccine almost exclusively to wealthy nations, the New York Times reported over the weekend.

  • Pfizer, on the other hand, has agreed to sell its vaccine at a low price to the U.S. government to donate to lower-income countries.
  • Tensions have been brewing for between Moderna and the administration for a while, but previously over booster shots.

Yes, but: Activists speaking on the panel said that it's time for the federal government to give up on Moderna voluntarily taking action, and to take much more aggressive steps to increase global vaccine capacity.

  • And it's not just activists. A group of Democratic lawmakers, led by Sen. Elizabeth Warren, wrote a letter to the Biden administration yesterday with a similar message, the Washington Post reports.
  • "Despite receiving huge sums of public funding from American taxpayers, Moderna has refused calls to share its technology, including from the U.S. government," the lawmakers wrote, pressing the administration for more information about the federal government's contract with Moderna and what rights it has to the company's vaccine data.

What they're saying: "We are committed to doubling our manufacturing and expanding supply even further until our vaccine is no longer needed in low-income countries," Moderna CEO Stéphane Bancel recently wrote in a letter outlining the company's strategy to increase vaccine access.

Between the lines: It's unclear what rights the U.S. government has to share information on how to make the Moderna vaccine with the world, which is what some activists want it to do.

  • Kessler said that the Defense Production Act "is probably the strongest authority, and that does give the president the authority to allocate doses."
  • But redirecting doses doesn't solve the problem of the total amount of vaccine available around the globe. Sharing the vaccine recipe, on the other hand, would help more manufacturers make it.

The bottom line: "We need the Biden administration to step up, because at the end of the day ... we're not sitting across from the heads of Pfizer and Moderna," said Zain Rizvi of Public Citizen.

  • "We can't tell them what to do. COVAX can't tell them what to do .... There's a singular unique power that the U.S. government has."

Go deeper

Jan 15, 2022 - Health

Experts warn of more COVID-19 variants after Omicron

Three COVID-19 testing companies place testing locations outside Grand Central Terminal on Jan. 14 in New York City. Photo: Alexi Rosenfeld/Getty Images

Experts are warning that subsequent COVID-19 variants are likely to come after Omicron, AP reports.

Why it matters: The warnings come as there's no guarantee that subsequent variants "will cause milder illness or that existing vaccines will work against them," underscoring the need for widespread vaccination, AP writes.

Updated Jan 14, 2022 - World

HRW criticizes Biden over "mixed signals" on human rights

Photo: Dustin Chambers/Bloomberg via Getty Images

Human Rights Watch criticized President Biden and other leaders of democratic nations for sending "mixed signals" on human rights in its annual World Report published on Thursday, saying they "are not meeting the challenges before them."

Why it matters: Though Biden pledged to put human rights at the center of his foreign policy, HRW Executive Director Kenneth Roth wrote that weapon sales to repressive governments and public reticence on certain human rights violations place those promises in question.

Updated 1 hour ago - Science

This powerful new accelerator looks for keys to the center of atoms

Illustration: Eniola Odetunde/Axios

Nuclear physicists trying to piece together how atoms are built are about to get a powerful new tool.

Why it matters: When the Facility for Rare Isotope Beams begins experiments later this spring, physicists from around the world will use the particle accelerator to better understand the inner workings of atoms that make up all the matter that can be seen in the universe.